Articles by Michelle Hoffman - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Michelle Hoffman

Quality Issues Redux

As we get ready to begin the New Year, let's hope some quality resolutions are made.
Dec 2, 2010

As we get ready to begin the New Year, let's hope some quality resolutions are made.

Riding the Employment Roller Coaster

2010 came with pay raises for those still employed and anxiety for all. This article contains bonus online material.
Dec 2, 2010

2010 came with pay raises for those still employed and anxiety for all. This article contains bonus online material.

Automated Inspection of Pharmaceutical Products

A conversation with Mike de la Montaigne, president of Eisai Machinery, USA Inc., about the possibilities for conducting fully automated product inspections.
Nov 2, 2010

A conversation with Mike de la Montaigne, president of Eisai Machinery, USA Inc., about the possibilities for conducting fully automated product inspections.

Novartis's Influenza Vaccine Program: A conversation with Matthew Stober, global head of technical operations for Novartis

Oct 2, 2010

Novartis' Matthew Stober discusses vaccine manufacturing, including egg- and cell-based systems.

Vaccine Manufacturing Reborn

Drugmakers hatch new manufacturing paradigms in the wake of the 2009 H1N1 influenza pandemic.
Oct 2, 2010

Drugmakers hatch new manufacturing paradigms in the wake of the 2009 H1N1 influenza pandemic.

This Again?

The reopened debate over embryonic-stem-cell research could stifle many other scientific pursuits.
Oct 2, 2010

The reopened debate over embryonic-stem-cell research could stifle many other scientific pursuits.

Survey Says...

New data provide insight into pharma-industry professionals' daily lives.
Sep 2, 2010

New data provide insight into pharma-industry professionals' daily lives.

An Ounce of Prevention

Industry's focus on cost cutting has led to a dangerous gap in training and knowledge.
Aug 2, 2010

Industry's focus on cost cutting has led to a dangerous gap in training and knowledge.

It takes a World

With more hands in the manufacturing pot, a good contingency plan is crucial to success.
Aug 1, 2010

With more hands in the manufacturing pot, a good contingency plan is crucial to success.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
8%
Protecting the supply chain
42%
Expedited reviews of drug submissions
8%
More stakeholder involvement
13%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search
Click here